NCT04335994 · RECRUITING

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing

This trial compares two ways of testing for sleep apnea in people with memory problems or dementia: a sleep test done at home versus an overnight stay in a sleep lab. The main question is which approach gets more people to actually finish testing within six months. It is not a drug study, and the phase is not applicable.

You may qualify if

  • Evidence of cognitive impairment by any one of: (i) Montreal Cognitive Assessment (MoCA) score of 13-28, or (ii) Mini Mental State Examination (MMSE) score of 18-30, or (iii) Toronto Cognitive Assessment (TorCA) score ≤281.
  • A diagnosis of: (i) Single-domain amnestic or multiple cognitive domain (with one feature being amnestic) Mild Cognitive Impairment due to Alzheimer's disease (AD); or (ii) Probable AD dementia; or (iii) Possible AD dementia due to limited concomitant cerebrovascular disease; or (iv) Probable Vascular dementia or Vascular Mild Cognitive Impairment, as per the 2011 American Heart Association Scientific Statement; or (v) Patients with a suspected neurodegenerative condition known to be associated with non-OSA sleep disorders (e.g. Parkinson's disease-related dementia and dementia with Lewy Bodies); and/or (vi) Mixed disease
  • Have the competency to provide informed consent, or the availability of a substitute decision maker/caregiver who can provide consent (if needed).
  • The availability of a caregiver to assist in the completion of HSAT or iPSG, if needed.

You're excluded if

  • Prior diagnosis of OSA within the last 2 years
  • Patients already using CPAP or a dental appliance for previously diagnosed OSA.
  • A known contraindication for the use of the HSAT that will be used in this study: (a) Moderate to severe pulmonary disease or congestive heart failure that could compromise the validity of the HSAT results (in users of the ApneaLink); (b) Permanent pacemaker or history of sustained non-sinus cardiac arrhythmia (in users of the WatchPAT).
  • Any medical device that would interfere with the placement of the HSAT
  • Significant physical impairment or language barrier that would restrict the ability to use the HSAT or complete the study assessments.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-08-20

View full record on ClinicalTrials.gov

All APOE4 clinical trials